Uncategorized

FDA’s leadership void leaves biotech with renewed ‘uncertainty’

Published

on

Marty Makary’s resignation leaves the agency with temporary directors in three top positions, and a number of newly instituted policies with an unclear future.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version